SCHEMBL9604220

SCHEMBL9604220

C[C@@H](Cc1c[nH]c(=S)[nH]1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A4 Q9H015 1/20 0.55
APAF1 O14727 3/20 0.42
POLB P06746 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.42
RECQL P46063 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM3B Q7LBC6 1/20 0.40
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.32
TBXAS1 P24557 2/20 0.31
MME P08473 3/20 0.31
ACE P12821 3/20 0.31
GAA P10253 1/20 0.31
GFER P55789 1/20 0.31
GABRR1 P24046 2/20 0.31
RXRA P19793 1/20 0.31
NR4A2 P43354 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25661031 0.68 APAF1 (0.47) APAF1POLBKDM4EMAPTRECQL
SCHEMBL15012539 0.67 APAF1 (0.54) APAF1POLBKDM4EMAPTRECQL
SCHEMBL791747 0.67 CYP3A4 (0.65) KDM4EMAPTKMT2ALMNATBXAS1
SCHEMBL14411160 0.67 CYP3A4 (0.65) KDM4EMAPTKMT2ALMNATBXAS1
SCHEMBL29062772 0.67 APAF1 (0.40) APAF1POLBKDM4EMAPTRECQL
SCHEMBL5159413 0.62 ADAMTS4 (0.54) APAF1POLBKDM4EMAPTRECQL
SCHEMBL11237591 0.62 TBXAS1 (0.59) LMNATBXAS1MMEACECYP1A2
SCHEMBL18072719 0.61 APAF1 (0.41) APAF1POLBKDM4EMAPTRECQL
SCHEMBL25661026 0.61 CAPN1 (0.44) APAF1POLBKDM4EMAPTRECQL
SCHEMBL3670921 0.60 APAF1 (0.40) APAF1POLBKDM4EMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170305865-A1 PROCESS FOR SYNTHESIZING ERGOTHIONEINE AND RELATED COMPOUNDS UNIVERSITY OF CAPE TOWN (ZA) 2017-10-26 US disclosed
US-8399500-B2 Method of synthesizing ergothioneine and analogs TETRAHEDRON (FR) 2013-03-19 US disclosed
US-20120136159-A1 THE METHOD OF SYNTHESIZING ERGOTHIONEINE AND ANALOGS TERTRAHEDRON (FR) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136159-A1 THE METHOD OF SYNTHESIZING ERGOTHIONEINE AND ANALOGS TST, SLC6A12, TTPA SLC22A4 331/4885APAF1 4409/4885POLB 1406/4885
US-20170305865-A1 PROCESS FOR SYNTHESIZING ERGOTHIONEINE AND RELATED COMPOUNDS CTH, FTH1, TXN SLC22A4 1267/4885APAF1 4385/4885POLB 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.